SEARCH RESULTS FOR: "Tag: PHAS"
REFINE YOUR SEARCH:
ARTICLES/BLOGS
2019(3)
CATEGORIES
Buzz Stocks(3)

6/18/2019 9:58 AM
Biotechnology concern PhaseBio Pharmaceuticals Inc (NASDAQ:PHAS) unveiled impressive preliminary data from a mid-stage study of its PB2452 therapy, used to reverse the effects of antiplatelet agents...
4/9/2019 9:57 AM
Near the bottom of the Nasdaq this morning is Zogenix, Inc. (NASDAQ:ZGNX), down 24.8% to trade at $38.97, after the Food and Drug Administration (FDA) refused to review the drugmaker's marketing appl...
3/18/2019 10:22 AM
Two biotech stocks have nearly doubled in value today, and sit near the top of the Nasdaq. First up, PhaseBio Pharmaceuticals Inc (NASDAQ:PHAS) is up 75.3% to trade at $6.52, and earlier nabbed a rec...
PEOPLE ALSO SEARCH FOR

Partnercenter